Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

SIB-Norwegian Version, Validation and Reliability Study

This study has been completed.
Sponsor:
Information provided by:
Sykehuset Innlandet HF
ClinicalTrials.gov Identifier:
NCT00449384
First received: March 19, 2007
Last updated: July 2, 2007
Last verified: July 2007
  Purpose

The purpose of this study is to validate and to test interrater reliability for the Norwgian version of Severe Impairment Battery (SIB).


Condition Intervention
Dementia
Diagnostic Tests, Routine
Behavioral: Diagnostic Screening

Study Type: Observational
Study Design: Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Cross-Sectional
Official Title: Severe Impairment Study - Norwegian Version. A Validation and Reliability Study.

Resource links provided by NLM:


Further study details as provided by Sykehuset Innlandet HF:

Enrollment: 59
Study Start Date: February 2007
Study Completion Date: May 2007
Detailed Description:

The study will include 60 persons with mild to severe dementia. To test the validation of SIB, we will interview the included persons with Severe Impairment Battery (SIB) and compare the results with Clinical Dementia Rating (CDV)reported by their nurses. To test interrater reliability 30 of the included persons will be interviewed with SIB by two different raters, and the two raters results will be compared.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Dementia, mild to severe.
  • Nursing Home resident

Exclusion Criteria:

  • No ability to write or read.
  • Physical handicapped, unable to use hands.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00449384

Locations
Norway
Sykehuset Innlandet HF - Sanderud
Ottestad, Oppland, Norway, 2312
Sponsors and Collaborators
Sykehuset Innlandet HF
Investigators
Study Chair: Knut Engedal, PhD The Norwegian Centre for Dementia Research (NCDR), Norway
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00449384     History of Changes
Other Study ID Numbers: F06002
Study First Received: March 19, 2007
Last Updated: July 2, 2007
Health Authority: Norway: Norwegian Social Science Data Services
Norway:National Committee for Medical and Health Research Ethics

Keywords provided by Sykehuset Innlandet HF:
Severe Impairment Battery
Clinical Dementia Rating

Additional relevant MeSH terms:
Dementia
Brain Diseases
Central Nervous System Diseases
Delirium, Dementia, Amnestic, Cognitive Disorders
Mental Disorders
Nervous System Diseases

ClinicalTrials.gov processed this record on November 27, 2014